Life Science Marketing Radio Chris Conner

David Ormesher, the CEO of CGLife, and I had a conversation about communicating science broadly to the public and within the scientific community. David went immediately to the power of storytelling in making science approachable. He highlighted the hero’s journey, the narrative arc used in literature and film, as a powerful tool to engage various audiences, whether they are scientists, physicians, patients, or the general public.
That narrative of the hero’s journey applies to patients and caregivers as well as scientist looking for breakthroughs. Not only can it help demystify science but it can also create emotional connections that make complex scientific concepts more relatable and engaging for the general public.
I think it’s important for society to understand and appreciate the work of scientists as well as understand how science is done especially when the details might not seem immediately relevant to them. By highlighting the human element and the persistence required in scientific exploration, we can help the public understand that scientists are ordinary people with an extraordinary commitment to solving complex problems. This can shift the public perception from seeing science as something inaccessible to recognizing it as a collective effort aimed at improving lives as well as simply appreciating the universe we live in.
What does this mean for life science marketers? David gave us a complete primer on the journey of a new medical product from inception to market launch. I was roughly aware of the roles various teams play in bringing a new drug to market. He covered the spectrum and filled in the details for me. Market insight, brand development, and market shaping involves understanding the needs of both physicians and patients, conducting extensive research, and building awareness through unbranded communications. As has come up several times over the years on this podcast, the importance of early engagement with healthcare professionals and patients before a product is approved can not be overstated. It helps ensure that by the time a drug is approved, there is demand and a well-informed audience.
It's that ability to personalize content that is also key. And this is where not only the agencies of the future that we need to help shepherd these products from clinical development through approval, launch and growth, they need to understand the science. They also need to understand that digital component of targeting, segmentation, (and) personalization.
Data and analytics play a critical role in this process. By capturing and analyzing data from the early stages, companies can refine their marketing strategies, personalize content, and measure the effectiveness of their campaigns. This data-driven approach ensures that the communication is relevant and impactful, reaching the right audience with the right message at the right time.
One aspect I found particularly interesting was the preparation for day zero – the day the FDA approves a new drug. David described having all the marketing materials ready, including a “day one” website and direct email marketing. At the same time, a launch team needs to be prepared to very quickly make any changes required for labeling, etc. when the approval comes along.
Finally, we touched on the challenges of educating physicians about the latest medical advancements. For a doctor who completed medical school 20 years ago, and has been seeing patients all day every day, keeping up to date is near impossible. Highly targeted communications including bite-sized, relevant, and easily accessible content, such as short video interviews and 3D animations can help physicians keep up with the latest developments.
As marketers, there is plenty of work to be done to keep both the public and people in the healthcare sector educated on the value of the science being done, ultimately helping patients find the treatments they need.
Your deepest insights are your best brandin

By now, I imagine most of you have interacted with ChatGPT in some way. You can use it to summarize a document, brainstorm a campaign or plan a vacation away from technology. The capabilities are mind-boggling and the BS (if you detect it) is amusing. All that aside, how can you use an internal vertical GPT to serve your customers?
I spoke to Ian Birkby, CEO of AZONetwork about Azthena, the internal vertical GPT they built as an AI assistant deployed on their various websites to help users find relevant news and product information. If you are not familiar with AZONetwork, Chat GPT describes them like this:
The AZoNetwork is a company that specializes in digital marketing and content solutions within the science, healthcare, and technology sectors. They provide a range of services aimed at connecting scientific, medical, and technology communities globally. These services include content creation, marketing strategies, and communication solutions designed to disseminate knowledge and promote products through various online platforms. AZoNetwork operates several websites that publish articles, news, and resources relevant to professionals in these fields, helping them to stay informed about the latest developments and technologies.

As a media and marketing company, AZONetwork has a lot of content, over a million assets, by Ian’s estimate. This is the content was used to train Azthena to to answer users queries.
The value of this type of GPT is that the data it has been trained on has been reviewed and vetted by humans in the course of publication over many years. The same can’t be said for everything one finds on the internet, some of which ends up in the answers to your ChatGPT queries, not to mention outright hallucinations.
General LLMs, if I'm going to exaggerate, are a mile wide and a few inches deep. We're trying to be, you know, maybe 12 inches wide, but three foot deep… - Ian Birkby
Azthena took nine months to build. That was impressive to me given that includes putting some structure around all of their content.
The quality of the output should enhance the customer experience by providing specific answers to queries along with relevant references.
If you find this helpful, it kind of makes sense to subscribe, doesn’t it?
Ian and I discussed what this will mean for companies, buyers and human creativity broadly.
External GPTs trained on the same broad collections of data may all end up homogenized. How will you differentiate your company to be a source of unique and valuable (essential) information? Building your own specialized GPT is one possible answer.
We agreed that the buyer’s journey will change. Once people adapt to the new approach (this will take some time but too much), they’ll expect to find answers and recommended next steps regarding what to look for or look at along the way to a purchase. No more clicking through multiple links hoping to find the best information. As I write that last sentence, I’m stunned at how quickly we are spoiled by new technologies. I’m old enough to remember mailing away to get a catalog or brochure from one vendor! If you are a marketer, you should be thinking about what comes next.
In reaction to this change, big information providers e.g. The Guardian, etc. are blocking crawlers from sucking up their information. Models built on search might also change. Will we have to pay for things that were free for the last 20 years?
Finally, I asked Ian about the future of human creativity.
…emotional intelligence… that's definitely an area where, you know, the human has still got a role I think, in that, very pure form of creativity… seeing what nobody else has seen before and thinking something different. You know, that I still think there's mileage in, in humans having a role to play there. However, there's probably 80 percent of the drudgery-related tasks that we all face that are going to end up sitting on the desk of AI.
But for those routine tasks, th

Susanna Harris is the Director of Community at Breakout Ventures. She is also the Founder of PhD Balance, a collaborative community empowering graduate students to build their personal and professional resilience and the 2023 recipient of the SAMPS Young Person of the Year Award.
This episode is a little different. For the last couple of years, I have interviewed the winner of that SAMPS award on this podcast. Susanna has been a guest before and although we’ve chatted a few times since and both live in the Bay Area, we had never met face to face. Susanna mentioned hiking in one of our calls so I thought this would be an opportunity try something new. I suggested we meet up for a hike and record some stuff along the way. Thank you Susanna for being game for one more experiment.
We had a free-flowing conversation covering our inspirations in science, science communication, marketing, career paths, longevity, mental health, and more. AI, psychedelics and The Andromeda Strain all came up as well. Give it a listen to find out the context.
I typically focus these episodes around a theme and try to point toward a specific takeaway. While there is a thread to the topics we discussed, the takeaway for me this time was simply about the value of conversation. I trust that the listeners to this podcast will learn something about each of us and may be prompted to think about something they heard from a new perspective.
As a listener, you don’t have to be part of a conversation to benefit from it. That’s the magic of this medium. You can listen in as if you were there. Taking that beyond podcasts, consider the value of people listening to your team members, executives and subject matter experts in their natural, unscripted style. Podcast listeners report (and I can verify this both as a host and a listener) that they feel like they know the people they hear from regularly. There is a level of know, like, and trust that is hard to replicate except face-to-face.
Finally, one never knows where having a conversation will lead in the long run. I don’t even remember how Susanna and I connected initially. Yet here we were, 3 years later, hiking the hills, sharing our experiences in science and creating unique content along the way. If we get a chance to help one another out in the future, that would be icing on the cake. It all started with a conversation.
Mentioned in this episode:
Books: Where Good Ideas Come From by Steven Johnson
The End of the World is Just The Beginning by Peter Zeihan
Movie: The Andromeda Strain (also a book by Michael Crichton)
Your deepest insights are your best branding. I’d love to help you share them. Chat with me about custom content for your life science brand. Or visit my website.




This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com

Jeffrey Kiplinger is the co-founder and partner at Selling Science, a consulting firm dedicated to helping life science, contract research, and tools companies boost revenue by building and optimizing their scientific sales teams. He is also the author of the book "Expert to Entrepreneur."
Jeff shared his personal journey from obtaining a PhD in organic chemistry in the late '80s to his corporate experience with Pfizer. He highlighted the frustrations he faced being siloed in his role and the desire to take his expertise on the road.
I appreciate his perspective on the disconnect many scientists face when building businesses. I guess I would say, your expertise is the product, but it is not the business. I’m still chewing on that one as I think there is a lot to be learned from that. Jeff emphasized the importance of viewing the business as an entity itself, separate from the scientific expertise it offers, and focusing on growing the business side.
Personally, I find marketing easy (talking about what I do). But sales is hard (asking for money). We talked about that and how to find the right people for your offering, stressing the need to identify the ideal customer and tailor marketing efforts to address their specific problems.
What is, what do you do that's provided real value for your customers in the past? And the easiest way to find that out is to ask them. And that's also something that we're terrified of doing.
I asked him about a quote from Brian Tracy. “Sales is just a transfer of enthusiasm.” When you believe in what you have, you can have a conversation and talk about why you are enthusiastic. But first you need to find out if the person in front of you has a problem you can solve.
If you find this helpful, it kind of makes sense to subscribe, doesn’t it?
Thanks for spending some time here, either way.
The conversation also touched on hiring experienced salespeople, both within and outside the scientific domain, and the critical factor of finding the perfect customer. Jeff outlined the significance of defining an ideal customer profile, which guides marketing efforts and ensures a more focused and effective approach. Does the salespersons skills and experience match what you are trying to do? Do they have the right mix of science and sales expertise? For example, selling from a catalog is different from selling a solution comprising components from a catalog.
If you're buying somebody's expertise in your science and they can't sell, that's a wasted investment. If you're buying somebody's network and their network isn't your ideal customer base, that's a waste.
…I guess what I see is when people hire experienced sales reps or senior people who've already got field experience, very frequently they're not looking at whether that person is a match for what you're trying to achieve. They might be a match for your company, they might be a match in terms of the revenue they've produced in the past, but are you really checking them against what the company is trying to do?
If you are on the road to selling your hard-earned scientific expertise, you should definitely give this episode a listen.
Your deepest insights are your best branding. I’d love to help you share them. Chat with me about custom content for your life science brand. Or visit my website.


This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com

Note: For this episode, I asked ChatGPT to write a summary based on the transcript of our conversation. I enjoy doing these interviews and consider myself a decent writer. However, it takes a lot of time each week to write a summary that I find minimally satisfying and acceptable. You deserve better and I can put my efforts to better use elsewhere or upgrading the whole experience here. I did lightly edit this to make it sound as if I could have written it. This is my second attempt following some feedback from a respected colleague (you know who you are). I’m beginning to see how my own style differs from ChatGPT, even if what it produces is perfectly readable, but somewhat less memorable. Let me know what you think in the comments.
Miranda Lipton is a talented freelance writer, photographer, and multimedia storyteller. In this episode we talked about earned media from a freelancer's perspective, focusing on how companies can collaborate with freelancers to get their stories published in widely read publications. Our discussion centered around Miranda's recent success in securing a feature in Fast Company about cultivated meat from fish. Our conversation should be enlightening for both freelancers and the companies that work with them.
Miranda's Journey into Freelance Writing
Miranda journey into freelance writing began in high school, and continued at the local town newspaper, a path that eventually led her to major in journalism at Ohio State University. Her desire to explore different facets of storytelling, including writing and photography, drove her to the freelance world.
The Genesis of the Lab-Grown Fish Story
Miranda's fascination with food sustainability and innovation in the past few years led her to investigate the idea lab-grown fish. The idea for the article emerged from a deep dive into the world of lab-grown meat, a concept that had been around for nearly a decade. Miranda recognized a gap in coverage, particularly in the realm of lab-grown fish, which was an emerging and innovative field. This, combined with her passion for food sustainability, created the perfect recipe (ChatGPT made a pun!) for a compelling story. She did her research and interviewed folks at relevant companies, eventually leading to the publication of her story in Fast Company.
The Art of Pitching to Publications
I was curious about the pitch process. How did she get an articled idea accepted at Fast Company? She utilizes a consistent pitch outline, typically comprising two to three paragraphs that encapsulate the essence of the story. Miranda stressed the importance of familiarity with the publication's focus. In her case, she had been an avid reader of Fast Company for years, allowing her to confidently identify the magazine as an ideal platform for her lab-grown fish story. .
Navigating Interviews with Companies
While pitching to publications can be challenging, arranging interviews is more straightforward. Companies are generally eager to discuss their work. Her process involves reaching out to individuals at relevant companies, often beginning with CEOs or co-founders identified through LinkedIn. Of course, it’s important to gather a diverse range of perspectives to provide a well-rounded view of the subject.
Thanks for reading cc: Life Science! Subscribe for free to receive new posts and support my work.

Feedback and Challenges
I asked her if she had gotten any feedback. While direct feedback from readers is not common, she occasionally receives emails from individuals who have read her articles. The overarching response to her articles on topics like lab-grown and 3D-printed food often revolves around skepticism and the novelty of the subjects. Many readers express interest in these innovations as well as uncertainty about trying them. The unfamiliarity of concepts such as 3D-printed food explains their hesitation. She thinks that as research in these fields progresses, more people will embrace these innovations. I have s

All of us in the life sciences are in the business of making the world healthier. The instruments and reagents we sell and the technologies and therapies that result save lives.
A scientist (after a lot of research) will look at a disease or problem and say, “I think I can find a way to fix that.”
Can we, as an industry, look at trade shows like a scientist would, and ask, “How can we do this better and stick to our mission of making the world at least less sick if not healthier?”
If you’ve been with me for a while, you know I have a love-hate relationship with trade shows. When I was a MarCom director, events were by far the biggest part of my budget. I imagined all the other awesome campaigns I could execute with that money. And then there is the waste. The stuff that ends up in the hotel trash before you get back on the plane and the shipping of huge amounts of equipment all over the world.
On the other hand, if a lot of customers are going to be in one place at the same time… it makes sense to take your offering to them. And human connection is important.
I know it’s important because this episode came out of my trip to ADLM, the event formerly known as AACC.
Stuart Warrington is the CEO of Envoke. They create virtual demos to make your instruments accessible at more events and present a consistent story across the customer journey. More on that below.
Stuart is a filmmaker. He has been created videos for the likes of Thermo and Bio-Rad. Videos used to have a longer useful lifespan. Then his customers wanted new content at a faster pace that was more engaging. Stuart suggested video games.
“No. That’s not it.”
“How about a virtual demo?
“Yes!”
It turns out those are basically the same thing just packaged differently. (They are both virtual experiences that tell a story with the user as the hero.) Stories are the key here. (The crowd cheers.)
People need to tell their own story, right? And sales and training and all that is about that. It's like, how can I communicate the message of what this thing does in the most accurate possible way? And you need to give people freedom to craft that story. And that's why we do things the way we do them.
We make this story block library and it's loads of little clips. And in each clip tells its own individual message. And then your user, your sales rep, your engineer, your trainer can take from that library and craft this story. It might be about a really specific bit of qPCR on the qPCR devices in the platform. And you know your customer only really cares about that. So we give you the opportunity to just pull those bits in and tell a story that is about your product with your product rather than PowerPoint presentations and brochures and videos and things like that. It just takes that to a slightly higher level and it also then starts saving you loads of money on shipping. Right?
The result is that consistent experience for the user from the web to sales to training to maintenance and service. We talked about training people the same way pilots train. On a simulation. They can make mistakes without breaking an expensive piece of kit.
Not subscribed yet? It would mean a lot to me.
Thanks for spending some time here, either way.
In addition to the contribution to sustainability without shipping products, the ability to customize a story improves the sales process.
So one of our customers built a storyline for the event from the story block library. So they built something that was like, this is what we want to talk about. This is the story we're telling here. But then what it also did was they put on a QR code, so that you scan the QR code as your customer, and what you do is, you walk away with a different storyline that's specific for you, that's just about the thing that you were talking to him about.
It's all come from the same place, we've just pitched it slightly differently. So it's all come from that story block library, we've just created speci